Remove 2023 Remove Compliance Remove Public Health Remove Telemedicine
article thumbnail

Preparing for the End of the Public Health Emergency

YouCompli

CMS Updates to beneficiary PHE waivers that matter to healthcare compliance Sharon Parsley, JD, MBA, CHC, CHRC, contributes regularly to the YouCompli blog. In this article, she discusses several issues that hospitals and health systems need to consider as a result of the scheduled end of the COVID-19 public health emergency.

article thumbnail

Managing Healthcare Compliance in North Carolina

MedTrainer

As is the case with every state, there are distinctive challenges in the management of healthcare compliance in North Carolina, shaped by its own unique regulations. Keep scrolling for a summary of the crucial elements of healthcare compliance relevant to North Carolina.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Managing Healthcare Compliance in New Hampshire

MedTrainer

The New Hampshire Department of Health and Human Services (DHHS) , along with other state agencies, is responsible for enforcing these important rules. Ensuring healthcare compliance in New Hampshire involves maintaining both federal and state guidelines, while providing quality patient care.

article thumbnail

Managing Healthcare Compliance in Idaho

MedTrainer

State-specific governing bodies, such as the Bureau of Facility Standards , provide oversight with certain standards, adding a layer of complexity to successfully managing healthcare compliance in Idaho. Continue reading this overview for key aspects of healthcare compliance specific to the state of Idaho.

article thumbnail

DEA Proposes New Rules that Would Permanently Allow for Telemedicine Controlled Substance Prescriptions

Hall Render

On Friday, February 24, 2023, the Drug Enforcement Administration (“DEA”) proposed new regulations that would permanently allow for telemedicine-controlled substance prescriptions, including induction of medication assisted therapy (“MAT”) using buprenorphine. These telemedicine exceptions, however, are quite narrow (e.g.,

article thumbnail

DEA & SAMHSA Issue Temporary Rule Extending COVID-19 Telemedicine Flexibilities for Controlled Substances Prescribing Beyond the Termination of COVID-19 PHE

Hall Render

Notably, the Temporary Rule, which can be accessed here , extends the COVID-19 PHE telemedicine flexibilities (hereinafter, “telemedicine flexibilities”) for six months following the end of the PHE (through November 11, 2023).

article thumbnail

Stuck in the Middle with You: Licensing Reforms for Cross-State Telehealth

Bill of Health

This post launches a Digital Symposium on The Future of Telehealth Regulation, edited by Carmel Shachar, Assistant Clinical Professor of Law and Faculty Director of the Health Law and Policy Clinic at the Center for Health Law and Policy Innovation. The working group was funded by a grant from the Commonwealth Fund.

Licensing 124